上海招聘

Position Summary： Shanghai Genome Center is seeking a full time Technical Director to be part of our clinical laboratory team (day shift) based in Shanghai. At Shanghai Genome Center, we believe that all patients with cancer deserve to have access to molecularly informed therapy and clinical trials.

The Director will work for a clinical sequencing laboratory based in Shanghai, China. He/or she will be responsible for the overall clinical lab operation with focus on clinical reporting of molecular oncology results.

Location: Shanghai, China

Major Responsibilities:

1. Interprets and reports cancer genome sequencing result: Be responsible for reporting testing results promptly and accurately.

2. Ensures test methods selected have the capability of providing quality results and provide valuable information in clinical practice.

3. Implements new test programs, including test menu, analysis methods, and procedures related to genetic testing using next-generation sequencing technology and other genomics and molecular biology related methods.

4. Ensures new assay validation and verification procedures are adequate to determine accuracy, precision, and other pertinent performance characteristics of the method.

5. Ensures the establishment and maintenance of acceptable levels of analytical performance for each test interpretation and reporting system.

6. Ensures that corrective actions are taken and documented, whenever significant deviations from the laboratory’s established performance characteristics are identified, and patient test results are reported only when the system is functioning properly.

7. Ensures testing systems provide quality laboratory services across pre-analytic, analytic, to post-analytic phases. Maintains and improves quality system according to CLIA/CAP/ICL regulation.

Minimal qualification: MD or MD/PhD; 5 years of experience in CLIA/CAP laboratories.

Certification in ABMGG or ABP in Molecular Genetics Pathology is preferred but not a must.

Previous experience in signing out molecular oncology reports is highly preferred.

赛加基因，是一家国际领先的肿瘤精准医疗技术平台。赛加基因与知名仪器设备生产厂商战略合作共建国际先进的分子医学检测技术平台，也与国内外科研院所、临床机构和药厂全面合作，进行基于基因组学的临床研究和药物研发，在中国上海张江的上海国际医学园区拥有总面积 2300 平米的医学研发检验实验室，致力于提供: 1. 针对正常和高危人群的癌症风险评估、遗传性癌症诊断、以及癌症早期筛查指导，2. 针对癌症患者的肿瘤基因检测、靶向用药、疗效评估、预后监测，和 3. 辅助诊断，及新药研发等一整套肿瘤精准医疗的系统服务和解决方案，满足不同阶段癌症患者和高危易感人群的临床需求。


赛加基因的目标是缩短中国跟西方国家在技术上和临床应用上的差距，推动国内癌症基因检测和诊断达到世界一流水平，协助政府相关部门制定出用于指导中国人的癌症风险预测和干预措施的临床指南，协助建立行业内规范和标准。长期目标是做到癌症的早预防、早发现、早诊断、早治疗。在未来以预防为主的医疗体系中，对精准医疗整个行业起到助推作用。